Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression that has shown promising efficacy in four recent double-blind, randomized, sham-controlled trials (RCT) and a meta-analysis. This study is a RCT of tDCS in depressed patients, testing its efficacy in both unipolar and bipolar depression. Mood, cognitive test performance and biomarkers will be measured during the trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
120
Sham tDCS
Active tDCS
Emory University
Atlanta, Georgia, United States
Sheppard Pratt
Towson, Maryland, United States
Rowan University
Cherry Hill, New Jersey, United States
Duke University
Durham, North Carolina, United States
Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Time frame: 12 weeks
Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)
Time frame: 12 weeks
Montreal Cognitive Assessment (MoCA): Global Cognitive Function
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Texas Southwestern
Dallas, Texas, United States
University of New South Wales / Black Dog Institute
Sydney, New South Wales, Australia